Somatic DIS3 mutations in Multiple Myeloma arise early in clonal evolution, but are later counterselected due to toxicity
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
DIS3 encodes an essential ribonucleic subunit of the nuclear exosome complex, responsible for degrading RNA in the nucleus. Somatic DIS3 mutations drive translocations in B cells, leading to multiple myeloma (MM). Clinical data analysis reveals that 42% of DIS3 mutations occur at three recurrent residues (D479, D488, and R780). These mutations, deactivating DIS3 exonucleolytic activity, are never homozygous, often appearing as minor subclones in advanced MM. Surprisingly, mutant DIS3 alleles undergo loss-of-heterozygosity, correlating with frequent del(13q) encompassing DIS3. Overexpression of wild-type DIS3 enhances growth and viability of DIS3-mutated MM cells, while CRISPR-mediated knock-out of the mutant variant, followed by longitudinal co-culture, replicates its elimination through counterselection, observed in the natural course of the disease. In mice, the heterozygous DIS3 D479 mutation is embryolethal, confirming its dominant toxic effects. Transcriptome analysis of patients and cell lines reveals specific transcriptional signatures of DIS3 mutations with accumulation of non-coding unstable RNA species and including secondary indications of decreased proliferation. All these signatures are reversible upon mutant DIS3 loss-of-heterozygosity. DIS3 is an intriguing hit-and-run oncogene that drives MM, but is subsequently eliminated during clonal evolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, they are counter-selected in later stages of MM due to their inhibitory effects on cell proliferation58.”
From DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma (2026) · cites this paper as [58]
In the citing paper
“Notably, MM-associated DIS3 mutations are very specific to the protein regions responsible for its exoribonucleolytic activity.”
From DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma (2026) · cites this paper as [58]
In the citing paper
“These mutations inhibit or, in the case of recurrent mutations (D479, D488, and R780), completely abolish the exoribonucleolytic activity of this enzyme, exerting dominant-negative effects58.”
From DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma (2026) · cites this paper as [58]
In the citing paper
“Our attempts to generate mouse lines with recurrent MM DIS3 alleles failed because of strong dominant-negative effects, leading to early embryonic lethality58.”
From DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma (2026) · cites this paper as [58]
In the citing paper
“Unlike DIS3L2, however, DIS3 is an essential gene in mice (Kuliński et al. 2023) and flies (Hou et al. 2012).”
From DIS3L, cytoplasmic exosome catalytic subunit, is essential for development but not cell viability in mice. (2025) · cites this paper as Kuliński et al. 2023
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Lohr, J. G., Stojanov, P., Carter, S. L., Cruz-Gordillo, P., Lawrence, M. S., Auclair, D., Sougnez, C., Knoechel, B., Gould, J., Saksena, G., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2013.12.015 · Cited by 988
Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016
Cowan, A. J., Allen, C., Barac, A., Basaleem, H., Bensenor, I., Curado, M. P., Foreman, K., Gupta, R., Harvey, J., Hosgood, H. D., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.2128 · Cited by 631
Revisiting Global Gene Expression Analysis
Lovén, J., Orlando, D. A., Sigova, A. A., Lin, C. Y., Rahl, P. B., Burge, C. B., Levens, D. L., Lee, T. I., & Young, R. A. (2012) · Cell · doi:10.1016/j.cell.2012.10.012 · Cited by 616
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Walker, B. A., Mavrommatis, K., Wardell, C. P., Ashby, T. C., Bauer, M., Davies, F. E., Rosenthal, A., Wang, H., Qu, P., Hoering, A., et al. (2018) · Blood · doi:10.1182/blood-2018-03-840132 · Cited by 475
Noncoding RNA transcription targets AID to divergently transcribed loci in B cells
Pefanis, E., Wang, J., Rothschild, G., Lim, J., Chao, J., Rabadan, R., Economides, A. N., & Basu, U. (2014) · Nature · doi:10.1038/nature13580 · Cited by 201 · cited 1×
“DIS3 and the nuclear exosome have been shown to play a role in AID regulation 30–33 .”
BackgroundWeick, E.-M., Puno, M. R., Januszyk, K., Zinder, J. C., DiMattia, M. A., & Lima, C. D. (2018) · Cell · doi:10.1016/j.cell.2018.05.041 · Cited by 153 · cited 1×
“Although distant in the protein sequence, the residues are brought in close proximity in the active site of DIS3 34,35 , which structure was previously resolved by electron microscopy 34 .”
BackgroundMikulasova, A., Wardell, C. P., Murison, A., Boyle, E. M., Jackson, G. H., Smetana, J., Kufova, Z., Pour, L., Sandecka, V., Almasi, M., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.163766 · Cited by 101
Robinson, S., Oliver, A., Chevassut, T., & Newbury, S. (2015) · Biomolecules · doi:10.3390/biom5031515 · Cited by 71 · cited 1×
“DIS3 mutations in MM patients are associated with pleiotropic changes at the transcriptome level, which previously were proposed to drive oncogenesis 46 .”
BackgroundRole of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
Maura, F., Rustad, E. H., Yellapantula, V., Łuksza, M., Hoyos, D., Maclachlan, K. H., Diamond, B. T., Greenbaum, B. D., Morgan, G., Lesokhin, A., et al. (2020) · Leukemia · doi:10.1038/s41375-019-0689-0 · Cited by 50
Kuliński, T. M., Gewartowska, O., Mahé, M., Kasztelan, K., Durys, N., Stroynowska-Czerwińska, A., Jedynak-Slyvka, M., Owczarek, E. P., Chaudhury, D., Nowotny, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70386-3 · Cited by 7
Self-citation
Research works printed but not linked: 52
- 10.1038/nrclinonc.2016.122 · DOI · Paper page
- 2017, Multiple myeloma, Nat. Rev. Dis. Prim., 3, 1
- 10.3322/caac.21660 · DOI · Paper page
- 2019, Multiple Myeloma Genomics-A Concise Review, Narrat. Rev. Acta Medica Acad, 48, 57, 10.5644/ama2006-124.242 · DOI · Paper page
- 10.1038/leu.2014.70 · DOI · Paper page
- 10.1182/blood-2006-08-040410 · DOI · Paper page
- 10.1038/s41375-019-0627-1 · DOI
- Ohguchi, Y. & Ohguchi, H . DIS3: The Enigmatic Gene in Multiple Myeloma. International Journal of Molecular Sciences vol. 24 (2023). · DOI
- 2011, Initial genome sequencing and analysis of multiple myeloma, Nat. 2011 4717339, 471, 467
- 2019, Progress in the identification of gene mutations involved in multiple myeloma, Onco. Targets. Ther., 12, 4075, 10.2147/OTT.S205922 · DOI
- Mroczek, S. et al. The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myeloma. Nat. Commun. 8, (2017). · DOI · Paper page
- 10.1038/nsmb1184 · DOI · Paper page
- 10.1093/nar/gkt930 · DOI · Paper page
- 10.1101/gr.189597.115 · DOI · Paper page
- 10.1038/nature07480 · DOI · Paper page
- 10.1534/genetics.116.187930 · DOI · Paper page
- 10.1093/nar/gkv387 · DOI · Paper page
- 2022, DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome, Haematologica, 106, 921
- 1988, Cold-sensitive and caffeine-supersensitive mutants of the Schizosaccharomyces pombe dis genes implicated in sister chromatid separation during mitosis, EMBO J, 7, 1465, 10.1002/j.1460-2075.1988.tb02964.x · DOI · Paper page
- 10.1371/journal.pone.0000317 · DOI · Paper page
- 10.1038/s41467-018-02974-x · DOI · Paper page
- 10.1101/2023.07.27.550610 · DOI
- 10.1038/nri.2016.2 · DOI · Paper page
- 10.1016/j.tibs.2020.10.005 · DOI
- 10.1016/j.cell.2011.01.001 · DOI · Paper page
- 10.1126/sciimmunol.abe8931 · DOI
- 10.1016/j.cell.2017.03.043 · DOI · Paper page
- 10.1016/j.molcel.2008.02.018 · DOI · Paper page
- 10.1371/journal.pone.0131080 · DOI · Paper page
- 2019, Leukemia, 33, 2324
- 2015, Purification of Eukaryotic Exoribonucleases Following Heterologous Expression in Bacteria and Analysis of Their Biochemical Properties by In Vitro Enzymatic Assays, Methods Mol. Biol., 1259, 417, 10.1007/978-1-4939-2214-7_25 · DOI
- 10.1016/B978-0-12-800267-4.00001-8 · DOI · Paper page
- 10.1016/B978-0-12-387663-8.00005-3 · DOI
- 10.1038/nprot.2016.043 · DOI · Paper page
- 10.3324/haematol.2023.283274 · DOI · Paper page
- 2021, Noncoding RNA processing by DIS3 regulates chromosomal architecture and somatic hypermutation in B cells, Nat. Genet, 53, 230, 10.1038/s41588-020-00772-0 · DOI · Paper page
- 10.15252/embj.2021109700 · DOI · Paper page
- 10.1158/0008-5472.BCD-19-0068 · DOI · Paper page
- 10.1056/NEJMoa075290 · DOI · Paper page
- 2007, RB1 Haploinsufficiency Confers a Proliferation Advantage in Myeloma Cell Lines, Blood, 110, 2489, 10.1182/blood.V110.11.2489.2489 · doi:10.1182/blood.v110.11.2489.2489
- 10.1080/10428190600822128 · DOI · Paper page
- 10.1182/blood.V98.4.1271 · DOI · Paper page
- 10.1016/j.cell.2011.02.013 · DOI · Paper page
- Parmigiani, E. , Taylor, V. & Giachino, C . Oncogenic and Tumor-Suppressive Functions of NOTCH Signaling in Glioma. Cells 9, (2020). · DOI
- 2022, Notch signaling pathway: architecture, disease, and therapeutics, Signal Transduct. Target. Ther. 2022 71, 7, 1
- 10.1038/nrc1186 · DOI · Paper page
- 10.1371/journal.pone.0191962 · DOI · Paper page
- 2016, Dynamics of CDKN1A in Single Cells Defined by an Endogenous Fluorescent Tagging Toolkit, Cell Rep, 14, 1800, 10.1016/j.celrep.2016.01.045 · DOI · Paper page
- Dobin, A. et al. Sequence analysis STAR: ultrafast universal RNA-seq aligner. 29, 15– 21 (2013). · DOI · Paper page
- 10.1093/bioinformatics/btr509 · DOI · Paper page
- 10.1093/bioinformatics/btq293 · DOI · Paper page
- Liao, Y. , Smyth, G. K. & Shi, W . Sequence analysis featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. 30, 923– 930 (2014). · DOI · Paper page
Cited by
Kuliński, T. M., Gewartowska, O., Mahé, M., Kasztelan, K., Durys, N., Stroynowska-Czerwińska, A., Jedynak-Slyvka, M., Owczarek, E. P., Chaudhury, D., Nowotny, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70386-3 · Cited by 7
Self-citationBrouze, M., Szpila, M., Czerwińska, A. M., Antczak, W., Mroczek, S., Kuliński, T., Hojka-Osińska, A. M., Cysewski, D., Gewartowska, O., Adamska, D., et al. (2025) · RNA · doi:10.1261/rna.080350.124 · Cited by 6
Self-citation
Metadata
- Authors
- Kuliński, T. M., Gewartowska, O., Mroczek, S., Szpila, M., Sałas, K., Liudkovska, V., & Dziembowski, A.
- Publisher
- openRxiv
- Published
- 2023-07-27
- Cited by
- 4
- References
- 10
- Type
- Preprint
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Somatic DIS3 mutations in Multiple Myeloma arise early in clonal evolution, but are later counterselected due to toxicity. https://app.cochat.ai/papers/10.1101/2023.07.27.550471
- The paper
- Kuliński, T. M., Gewartowska, O., Mroczek, S., Szpila, M., Sałas, K., Liudkovska, V., & Dziembowski, A. (2023). Somatic DIS3 mutations in Multiple Myeloma arise early in clonal evolution, but are later counterselected due to toxicity. https://doi.org/10.1101/2023.07.27.550471
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.